Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App





VedaLab Showcases Comprehensive Portfolio for Rapid Diagnostic Testing

By LabMedica International staff writers
Posted on 18 Nov 2025

VEDALAB SA is presenting its comprehensive portfolio of rapid tests, immunodiagnostic reagents and point-of-care (POC) technologies at MEDICA 2025. More...

Exhibiting in Hall 1, Stand A64, the company is showcasing solutions designed for clinical laboratories, primary care settings, and supervised home testing.

VedaLab’s exhibitor profile at MEDICA 2026 highlights several key rapid test products: GLUTEN’ALARM is an immunochromatographic test for the qualitative detection of anti-tissue transglutaminase IgA antibodies associated with Gluten intolerance (celiac disease) in whole blood. STREPA’ALERT provides rapid detection of Group A Streptococcus from throat swabs for clinical and near patient use. Babycheck 1 WB, a whole blood pregnancy test, reflects the company’s experience in CE marked home use diagnostics. Additional highlighted products include URICHECK for rapid uric acid screening and VedaLab’s latex reagent line for routine serological and immunological applications.

Another major feature at the company’s booth is the EASY READER+ instrument. This POC device enables quantitative measurements from finger-prick whole blood samples using lateral flow rapid tests. The instrument includes a touchscreen interface, enhanced memory and internet-based upgrading. EASY READER+ and its associated quantitative tests are designed for use in physician offices, clinical laboratories and online pharmacy networks, as well as supervised consumer testing through diagnostic information providers.

Laboratory professionals, point-of-care coordinators and distribution partners attending MEDICA 2025 can visit Hall 1, Stand A64 to discover VedaLab's latest self-testing innovations and explore our full panel of solutions.

Related Links:
VedaLab


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.